AIF1L | Allograft inflammatory factor 1-like | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20522/146583_A_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16629/37314_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15715/37859_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD300LF | CD300 molecule-like family member f | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13712/117004_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2594/6570_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/37756/ihc_cell_selected_60x60.jpg) | ![](/images/12/106_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/55431/ihc_cell_selected_60x60.jpg) | ![](/images/32435/70987_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13323/30968_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63182/142047_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPR182 | G protein-coupled receptor 182 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27037/142398_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44535/99160_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
IL2RB | Interleukin 2 receptor, beta | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62657/139409_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins
| | ![](/images/4723/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4458/14041_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62570/146083_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21896/49187_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2301/if_selected_60x60.jpg) | | ![](/images/13967/30400_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
NKG2-E | Uncharacterized protein | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62570/146083_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49047/111260_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PITPNM3 | PITPNM family member 3 | Disease related genes
| | ![](/images/59005/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22432/133053_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins
| | ![](/images/40923/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40944/90010_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43734/97692_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
RENBP | Renin binding protein | Enzymes
| | | ![](/images/428/ihc_cell_selected_60x60.jpg) | ![](/images/522/904_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
SHANK3 | SH3 and multiple ankyrin repeat domains 3 | | | ![](/images_static/na_center.gif) | ![](/images/3446/ihc_cell_selected_60x60.jpg) | ![](/images/3446/11715_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14377/33569_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC5 | Sialic acid binding Ig-like lectin 5 | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24900/57350_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted membrane proteins Transporters
| | ![](/images/41329/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41004/90176_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30043/70681_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
VCAM1 | Vascular cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5426/18356_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |